-
-
-
-
-
-
-
Rogers (ROG) Tops Q4 EPS by 29c, Beats on Revenue; Offers Q1 Guidance
-
-
-
-
-
-
-
Genentech breaks ground on $700 million manufacturing facility in North Carolina
-
-
-
-
-
-
-
Roche (RHHBY) to invest $550 million for manufacturing hub expansion
-
-
-
-
-
-
-
FDA Approves Genentech’s Susvimo as Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
-
-
-
-
-
-
-
Genentech’s Vabysmo Showed Extended Durability, Continued Efficacy and a Consistent Safety Profile in Long-Term Diabetic Macular Edema (DME) Study
-
454,266 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

